Dications that target the DNA minor groove: Compound design and preparation, DNA interactions, cellular distribution and biological activity

W. David Wilson, Binh Nguyen, Farial A. Tanious, Amanda Mathis, James Edwin Hall, Chad E. Stephens, David W. Boykin

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Fluorescence microscopy of trypanosomes from drug treated mice shows that biologically active heterocyclic diamidines that target the DNA minor groove bind rapidly and specifically to parasite kinetoplast DNA (k-DNA). The observation that the kinetoplast is destroyed, generally within 24 hours, after drug treatment is very important for understanding the biological mechanism, and suggests that the diamidines may be inhibiting some critical opening/closing step of circular k-DNA. Given the uncertainties in the biological mechanism, we have taken an empirical approach to generating a variety of synthetic compounds and DNA minor groove interactions for development of improved and new biological activities. Furamidine, DB75, is a diphenyl-diamidine that has the curvature to match the DNA minor groove as expected in the classical groove interaction model. Surprisingly, a linear diamidine with a nitrogen rich linker has significantly stronger binding than furamidine due to favorable linker and water-mediated DNA interactions. The water interaction is very dependant on compound structure since other linear compounds do not have similar interactions. Change of one phenyl of furamidine to a benzimidazole does not significantly enhance DNA binding but additional conversion of the furan to a thiophene (DB818) yields a compound with ten times stronger binding. Structural analysis shows that DB818 has a very favorable curvature for optimizing minor groove interactions. It is clear that there are many ways for compounds to bind to k-DNA and exert specific effects on kinetoplast replication and/or transcription that are required to obtain an active compound.

Original languageEnglish (US)
Pages (from-to)389-408
Number of pages20
JournalCurrent Medicinal Chemistry - Anti-Cancer Agents
Volume5
Issue number4
DOIs
StatePublished - Jul 1 2005

Fingerprint

Pentamidine
Kinetoplast DNA
DNA
Circular DNA
Thiophenes
Trypanosomiasis
Water
Fluorescence Microscopy
Pharmaceutical Preparations
Uncertainty
Parasites
Nitrogen
furamidine

Keywords

  • Antiparasitic drugs
  • Antiparasitic mechanism of action
  • DNA minor groove
  • DNA-drug complexes
  • Drug uptake and distribution
  • Drug/prodrug design and synthesis
  • Kinetoplast

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Cancer Research

Cite this

Dications that target the DNA minor groove : Compound design and preparation, DNA interactions, cellular distribution and biological activity. / Wilson, W. David; Nguyen, Binh; Tanious, Farial A.; Mathis, Amanda; Hall, James Edwin; Stephens, Chad E.; Boykin, David W.

In: Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4, 01.07.2005, p. 389-408.

Research output: Contribution to journalArticle

Wilson, W. David ; Nguyen, Binh ; Tanious, Farial A. ; Mathis, Amanda ; Hall, James Edwin ; Stephens, Chad E. ; Boykin, David W. / Dications that target the DNA minor groove : Compound design and preparation, DNA interactions, cellular distribution and biological activity. In: Current Medicinal Chemistry - Anti-Cancer Agents. 2005 ; Vol. 5, No. 4. pp. 389-408.
@article{d40c9aa1ac7a4dd18a5d8e7a50dd148a,
title = "Dications that target the DNA minor groove: Compound design and preparation, DNA interactions, cellular distribution and biological activity",
abstract = "Fluorescence microscopy of trypanosomes from drug treated mice shows that biologically active heterocyclic diamidines that target the DNA minor groove bind rapidly and specifically to parasite kinetoplast DNA (k-DNA). The observation that the kinetoplast is destroyed, generally within 24 hours, after drug treatment is very important for understanding the biological mechanism, and suggests that the diamidines may be inhibiting some critical opening/closing step of circular k-DNA. Given the uncertainties in the biological mechanism, we have taken an empirical approach to generating a variety of synthetic compounds and DNA minor groove interactions for development of improved and new biological activities. Furamidine, DB75, is a diphenyl-diamidine that has the curvature to match the DNA minor groove as expected in the classical groove interaction model. Surprisingly, a linear diamidine with a nitrogen rich linker has significantly stronger binding than furamidine due to favorable linker and water-mediated DNA interactions. The water interaction is very dependant on compound structure since other linear compounds do not have similar interactions. Change of one phenyl of furamidine to a benzimidazole does not significantly enhance DNA binding but additional conversion of the furan to a thiophene (DB818) yields a compound with ten times stronger binding. Structural analysis shows that DB818 has a very favorable curvature for optimizing minor groove interactions. It is clear that there are many ways for compounds to bind to k-DNA and exert specific effects on kinetoplast replication and/or transcription that are required to obtain an active compound.",
keywords = "Antiparasitic drugs, Antiparasitic mechanism of action, DNA minor groove, DNA-drug complexes, Drug uptake and distribution, Drug/prodrug design and synthesis, Kinetoplast",
author = "Wilson, {W. David} and Binh Nguyen and Tanious, {Farial A.} and Amanda Mathis and Hall, {James Edwin} and Stephens, {Chad E.} and Boykin, {David W.}",
year = "2005",
month = "7",
day = "1",
doi = "10.2174/1568011054222319",
language = "English (US)",
volume = "5",
pages = "389--408",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Dications that target the DNA minor groove

T2 - Compound design and preparation, DNA interactions, cellular distribution and biological activity

AU - Wilson, W. David

AU - Nguyen, Binh

AU - Tanious, Farial A.

AU - Mathis, Amanda

AU - Hall, James Edwin

AU - Stephens, Chad E.

AU - Boykin, David W.

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Fluorescence microscopy of trypanosomes from drug treated mice shows that biologically active heterocyclic diamidines that target the DNA minor groove bind rapidly and specifically to parasite kinetoplast DNA (k-DNA). The observation that the kinetoplast is destroyed, generally within 24 hours, after drug treatment is very important for understanding the biological mechanism, and suggests that the diamidines may be inhibiting some critical opening/closing step of circular k-DNA. Given the uncertainties in the biological mechanism, we have taken an empirical approach to generating a variety of synthetic compounds and DNA minor groove interactions for development of improved and new biological activities. Furamidine, DB75, is a diphenyl-diamidine that has the curvature to match the DNA minor groove as expected in the classical groove interaction model. Surprisingly, a linear diamidine with a nitrogen rich linker has significantly stronger binding than furamidine due to favorable linker and water-mediated DNA interactions. The water interaction is very dependant on compound structure since other linear compounds do not have similar interactions. Change of one phenyl of furamidine to a benzimidazole does not significantly enhance DNA binding but additional conversion of the furan to a thiophene (DB818) yields a compound with ten times stronger binding. Structural analysis shows that DB818 has a very favorable curvature for optimizing minor groove interactions. It is clear that there are many ways for compounds to bind to k-DNA and exert specific effects on kinetoplast replication and/or transcription that are required to obtain an active compound.

AB - Fluorescence microscopy of trypanosomes from drug treated mice shows that biologically active heterocyclic diamidines that target the DNA minor groove bind rapidly and specifically to parasite kinetoplast DNA (k-DNA). The observation that the kinetoplast is destroyed, generally within 24 hours, after drug treatment is very important for understanding the biological mechanism, and suggests that the diamidines may be inhibiting some critical opening/closing step of circular k-DNA. Given the uncertainties in the biological mechanism, we have taken an empirical approach to generating a variety of synthetic compounds and DNA minor groove interactions for development of improved and new biological activities. Furamidine, DB75, is a diphenyl-diamidine that has the curvature to match the DNA minor groove as expected in the classical groove interaction model. Surprisingly, a linear diamidine with a nitrogen rich linker has significantly stronger binding than furamidine due to favorable linker and water-mediated DNA interactions. The water interaction is very dependant on compound structure since other linear compounds do not have similar interactions. Change of one phenyl of furamidine to a benzimidazole does not significantly enhance DNA binding but additional conversion of the furan to a thiophene (DB818) yields a compound with ten times stronger binding. Structural analysis shows that DB818 has a very favorable curvature for optimizing minor groove interactions. It is clear that there are many ways for compounds to bind to k-DNA and exert specific effects on kinetoplast replication and/or transcription that are required to obtain an active compound.

KW - Antiparasitic drugs

KW - Antiparasitic mechanism of action

KW - DNA minor groove

KW - DNA-drug complexes

KW - Drug uptake and distribution

KW - Drug/prodrug design and synthesis

KW - Kinetoplast

UR - http://www.scopus.com/inward/record.url?scp=22144474782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144474782&partnerID=8YFLogxK

U2 - 10.2174/1568011054222319

DO - 10.2174/1568011054222319

M3 - Article

C2 - 16101490

AN - SCOPUS:22144474782

VL - 5

SP - 389

EP - 408

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 4

ER -